AquaBounty Technologies Crecimiento futuro

Future controles de criterios 2/6

Se prevé que los beneficios de AquaBounty Technologies disminuyan en un 8.2% al año, mientras que se espera que sus ingresos anuales crezcan en un 23.2% al año. Se prevé que el BPA disminuya en un 2% por año. Se espera que la rentabilidad financiera sea de -29.3% en 3 años.

Información clave

-8.2%

Tasa de crecimiento de los beneficios

-2.0%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Biotechs	24.0%
Tasa de crecimiento de los ingresos	23.2%
Rentabilidad financiera futura	-29.3%
Cobertura de analistas	Low
Última actualización	16 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

AquaBounty Technologies' First Genetically Engineered Salmon On The Plate - Should You Join The Stream?

Jun 02

Here's Why AquaBounty Technologies (NASDAQ:AQB) Can Manage Its Debt Despite Losing Money

May 09

AquaBounty Technologies: Teach A Man To Fish And You Will Feed Him For A Lifetime

May 03

What Kind Of Shareholders Hold The Majority In AquaBounty Technologies, Inc.'s (NASDAQ:AQB) Shares?

Feb 10

Aquabounty Technologies launches stock offering; stock down ~5% after hours

Feb 03

Richard Huber Is The Independent Non-Executive Director of AquaBounty Technologies, Inc. (NASDAQ:AQB) And They Just Picked Up 16% More Shares

Dec 20

AquaBounty Technologies proposes public offering

Dec 09

Previsiones de crecimiento de beneficios e ingresos

NasdaqCM:AQB - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	1	-35	-29	-19	1
12/31/2025	2	-14	-167	-7	2
12/31/2024	1	-20	-90	-18	3
12/31/2023	2	-28	-93	-24	N/A
9/30/2023	2	-25	-110	-22	N/A
6/30/2023	2	-25	-106	-22	N/A
3/31/2023	3	-24	-106	-22	N/A
12/31/2022	3	-22	-88	-21	N/A
9/30/2022	3	-22	-70	-23	N/A
6/30/2022	3	-24	-55	-21	N/A
3/31/2022	2	-23	-32	-21	N/A
12/31/2021	1	-22	-26	-20	N/A
9/30/2021	1	-22	-25	-19	N/A
6/30/2021	0	-19	-23	-18	N/A
3/31/2021	0	-17	-21	-16	N/A
12/31/2020	0	-16	-19	-14	N/A
9/30/2020	0	-14	-17	-14	N/A
6/30/2020	0	-13	-16	-13	N/A
3/31/2020	0	-14	-15	-12	N/A
12/31/2019	0	-13	-14	-11	N/A
9/30/2019	0	-14	-13	-11	N/A
6/30/2019	0	-14	-12	-10	N/A
3/31/2019	0	-13	-12	-9	N/A
12/31/2018	0	-12	-14	-10	N/A
9/30/2018	0	-11	-15	-10	N/A
6/30/2018	0	-10	-16	-10	N/A
3/31/2018	0	-10	-30	-9	N/A
12/31/2017	0	-9	-28	-9	N/A
9/30/2017	0	-9	N/A	-9	N/A
6/30/2017	0	-9	N/A	-8	N/A
3/31/2017	N/A	-9	N/A	-8	N/A
12/31/2016	N/A	-8	N/A	-7	N/A
9/30/2016	N/A	-8	N/A	-7	N/A
6/30/2016	N/A	-7	N/A	-7	N/A
3/31/2016	N/A	-7	N/A	-7	N/A
12/31/2015	N/A	-7	N/A	-7	N/A
9/30/2015	N/A	-7	N/A	-7	N/A
6/30/2015	N/A	-7	N/A	-7	N/A
3/31/2015	N/A	-7	N/A	-7	N/A
12/31/2014	N/A	-7	N/A	-7	N/A
9/30/2014	N/A	-7	N/A	-6	N/A
6/30/2014	N/A	-6	N/A	-5	N/A
3/31/2014	N/A	-5	N/A	-5	N/A
12/31/2013	N/A	-5	N/A	-4	N/A
9/30/2013	N/A	-4	N/A	-4	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que AQB siga sin ser rentable en los próximos 3 años.

Beneficios vs. Mercado: Se prevé que AQB siga sin ser rentable en los próximos 3 años.

Beneficios de alto crecimiento: Se prevé que AQB siga sin ser rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (23.2% al año) de AQB crezcan más rápidamente que los del mercado US (8.1% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos (23.2% al año) de AQB crezcan más rápidamente que un 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: AQB se prevé que no sea rentable en 3 años.

AquaBounty Technologies Crecimiento futuro

Future controles de criterios 2/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus revenue estimates fall by 67%

Consensus revenue estimates increase by 10%

Consensus revenue estimates decrease by 20%

Consensus revenue estimates fall by 33%

Price target decreased to US$4.00

Price target decreased to US$4.00

Recent updates

AquaBounty Technologies, Inc., Annual General Meeting, May 23, 2024

Consensus revenue estimates fall by 67%

Full year 2023 earnings: EPS and revenues miss analyst expectations

New minor risk - Shareholder dilution

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

New major risk - Share price stability

New major risk - Market cap size

AquaBounty Technologies, Inc. Announces Board Changes

New minor risk - Share price stability

Consensus revenue estimates increase by 10%

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus revenue estimates decrease by 20%

Consensus revenue estimates fall by 33%

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Full year 2022 earnings: EPS in line with expectations, revenues disappoint

Director recently bought US$101k worth of stock

Price target decreased to US$4.00

High number of new directors

Price target decreased to US$4.00

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

AquaBounty Technologies Receives Non-Compliance Notice from Nasdaq

AquaBounty: Not Casting A Lure Yet

Consensus forecasts updated

High number of new directors

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

AquaBounty Technologies GAAP EPS of -$0.08, revenue of $1.07M

AquaBounty Technologies, Inc., Annual General Meeting, May 27, 2022

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target decreased to US$5.88

Consensus revenue estimates fall by 22%

AquaBounty CEO Sylvia Wulf - Genetically Modified Sustainable Salmon

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Third quarter 2021 earnings released: US$0.097 loss per share (vs US$0.094 loss in 3Q 2020)

Price target decreased to US$8.33

Second quarter 2021 earnings released: US$0.074 loss per share (vs US$0.11 loss in 2Q 2020)

Aquabounty Technologies, Inc. Receives Approval for the Sale of GE Atlantic Salmon in Brazil

Independent Non-Executive Director has left the company

AquaBounty Technologies' First Genetically Engineered Salmon On The Plate - Should You Join The Stream?

Consensus forecasts updated

Here's Why AquaBounty Technologies (NASDAQ:AQB) Can Manage Its Debt Despite Losing Money

First quarter 2021 earnings released: US$0.064 loss per share (vs US$0.12 loss in 1Q 2020)

AquaBounty Technologies: Teach A Man To Fish And You Will Feed Him For A Lifetime

Earnings beat expectations, revenue disappoints

New 90-day low: US$6.09

Analysts update estimates

AquaBounty Technologies, Inc. Elects Ricardo J. Alvarez as A Non-Executive Director

What Kind Of Shareholders Hold The Majority In AquaBounty Technologies, Inc.'s (NASDAQ:AQB) Shares?

AquaBounty Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $110.5 million.

Aquabounty Technologies launches stock offering; stock down ~5% after hours

New 90-day high: US$10.34

New 90-day high: US$9.74

Richard Huber Is The Independent Non-Executive Director of AquaBounty Technologies, Inc. (NASDAQ:AQB) And They Just Picked Up 16% More Shares

Analysts update estimates

AquaBounty Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $56.68 million.

AquaBounty Technologies proposes public offering

New 90-day high: US$5.80

Analysts lower revenue estimates to US$657.3k

Price target raised to US$4.83

Earnings beat expectations, revenue disappoints

New 90-day high: US$4.50

AquaBounty Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $27.5 million.

Earnings released

AquaBounty Technologies, Inc.(NasdaqCM:AQB) dropped from Russell Microcap Value Index

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento